肌瘤

CT检查在子宫肌瘤诊断中的临床价值

Clinic Value of CT Examination in the Uterine Myoma

不典型子宫肌瘤的CT与超声表现

Atypical CT and Ultrasonographic Manifestations of Uterine myoma

卵巢卵泡膜细胞瘤、纤维瘤与浆膜下子宫肌瘤的MR影像研究

MR Study of Ovarian Thecoma , Fibroma and Subserosal Leiomyoma

动态增强CT扫描对子宫肌瘤的诊断价值

The diagnostic value of dynamic enhanced CT scan to uterine leiomyomas

目的描述淋巴管肌瘤病的CT表现。

Objective To describe CT manifestations of lymphangioleiomyomatosis ( LAM ) .

胃肠造影、胃镜及胃部CT对胃平滑肌瘤诊断的对比研究

Comparative study of the diagnosis of stomach leiomyoma by gastroenterography , gastroscope and CT

胃平滑肌瘤CT表现以粘膜面连续性线样强化征为其特征性表现。

The CT characteristic features of leiomyoma were the continuous linear enhancement in mucosa .

肺淋巴管肌瘤病的高分辨率CT诊断

Diagnosis of pulmonary lymphangioleiomyomatosis by high resolution CT

CT和MRI诊断胆囊腺肌瘤病的比较研究

Comparison of CT and MRI for the diagnosis of adenomyomatosis of the gallbladder

15例子宫平滑肌瘤MRI征象分析

MRI of Uterine Leiomyomas : Report of 15 Cases

巨大子宫肌瘤的CT诊断

CT Diagnosis of Giant Hysteromyoma

子宫肌瘤患者血清SOD、MDA的观察

Determination of SOD , MDA in Serum of Patients with Uterine Myoma

X染色体失活和微卫星分析确定多发性子宫平滑肌瘤的独立克隆来源

Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis

95例直径≤2cm的平滑肌瘤经内镜推顶圈套法切除，无严重并发症发生。

95 cases of leiomyoma with diameter ≤ 2 cm were resected by push snare cauterization .

目的分析子宫平滑肌瘤细胞的DNA含量，并与同源的正常肌细胞相比较。

Objective To investigate the differences of biological aggressiveness in terms of the DNA content and cell cycle between the leiomyoma and myometrium .

目的总结13例不典型子宫肌瘤的CT与超声表现，以期提高其诊断与鉴别诊断的准确性。

Objective To summarize atypical CT and Ultrasonography ( US ) findings of uterine myoma in 13 cases , to improve its diagnostic accuracy .

子宫肌瘤组，对照组与正常组外周静脉血的E2浓度差异无统计学意义。

No statistical difference was found among the E2 concentrations of peripheral venous blood in patients with leiomyoma , endometriosis and healthy women .

目的探讨子宫上皮样平滑肌瘤（epithelioidleiomyoma，EL）的临床病理特征和生物学特性。

Purpose To investigate the clinicopathological and biological features of the uterine epithelioid leiomyoma ( EL ) .

子宫腺肌病与子宫肌瘤的临床、血清CA（125）及超声诊断的比较分析

The comparative analysis of the clinical characteristics 、 the detection of serum CA_ ( 125 ) and B-ultrasonic diagnosis between the adenomyosis and hysteromyoma

方法对比分析33例子宫腺肌病和42例子宫肌瘤的临床、血清CA（125）及B超资料。

Methods To compare the clinical characteristics 、 the detection of Serum CA_ ~ 125 and B-ultrasonic diagnosis in the 33 adenomyosis and 42 hysteromyoma .

目的研究子宫肌瘤患者雌激素受体（ER）的改变及其性激素调节。

Objective To study the changes of estrogen receptor ( ER ) in patients with uterine myoma and its sex hormone regulation .

雄激素受体第一外显子CAG重复序列长度多态性与子宫平滑肌瘤遗传易感性有关

CAG repeat polymorphism at androgen receptor gene exon 1 is associated with predisposition to uterine leiomyoma

基于NBC的子宫肌瘤辅助诊断方法

Assisted Diagnosis for Uterine Myoma Based on NBC

子宫肌瘤中IGF-1受体的变化及其与雌、孕激素受体、PCNA和Bcl-2的关系

Changes of IGF-1 receptors in uterine leiomyoma and its correlation with estrogen receptor , progesterone receptor , pcna and Bcl-2

目前HIFU技术已应用于临床治疗子宫肌瘤，且疗效肯定。

Thus , HIFU technology has been effectively applied to the current clinical treatment of uterine leiomyomas .

采用实时荧光定量PCR、westernblot及荧光免疫组织化学方法探查FBN-1mRNA和蛋白在体外培养的子宫肌瘤平滑肌细胞中的表达。

FBN-1 mRNA and protein expressions in LSMC and myometrium smooth muscle cells ( MSMC ) were examined by quantitative real time PCR , Western blot and Immunofluorescence staining .

子宫腺肌病组血清CA（125）水平明显升高，其阳性率为81.8%，显著高于子宫肌瘤组（阳性率为4.76%）（P<0.05）。

The positive rate of detection of serum CA_ ~ 125 of two groups were 81.8 % and 4.76 % respectively and has significant difference ( P < 0.05 ) .

目的：探讨UAE治疗子宫肌瘤的临床效果。

Objective : To discuss the clinical value and effectivity by using UAE in treating hysteromyoma .

目的：研究bcl-2蛋白和增殖细胞核抗原（PCNA）在子宫肌瘤和正常子宫肌层中的表达及其在肌瘤发生发展中的作用。

Objective : To study the expression of bcl-2 protein and proliferating cell nuclear antigen ( PCNA ) in uterine leiomyomas and in normal myometrium .

血清激素水平和子宫ER、PR含量与子宫肌瘤生长的关系

Study on the Relationship Between the Growth of Uterine Leiomyoma and the Level of Hormone in Serum and the Consent of ER and PR in Uterus